GI
ARCT icon

GAMMA Investing’s Arcturus Therapeutics ARCT Stock Holding History

GAMMA Investing’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8K Buy
1,750
+244
+16% +$1.92K ﹤0.01% 3127
2026
Q1 		$11.6K Buy
1,506
+1,044
+226% +$7.62K ﹤0.01% 2995
2025
Q4 		$2.83K Sell
462
-162
-26% -$1.75K ﹤0.01% 3500
2025
Q3 		$11.5K Buy
624
+43
+7% +$691 ﹤0.01% 2817
2025
Q2 		$7.56K Buy
581
+87
+18% +$1.03K ﹤0.01% 2950
2025
Q1 		$5.23K Buy
494
+348
+238% +$5.52K ﹤0.01% 3070
2024
Q4 		$2.48K Buy
146
+29
+25% +$546 ﹤0.01% 3157
2024
Q3 		$2.72K Sell
117
-61
-34% -$1.3K ﹤0.01% 2968
2024
Q2 		$4.33K Buy
178
+124
+230% +$3.76K ﹤0.01% 2636
2024
Q1 		$1.82K Buy
54
+5
+10% +$177 ﹤0.01% 2774
2023
Q4 		$1.62K Buy
+49
New +$1.17K ﹤0.01% 2648

Other funds holding ARCT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return